
Scynor Pharmaceuticals Private Limited
About Scynor Pharmaceuticals Private Limited
Data last updated:
Scynor Pharmaceuticals Private Limited is a private limited company based in Raisen, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 12 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2021PTC054905.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Deepak Kumar Tiwari and Phul Kumari Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 215 Sheetal Mega City Phase 2 Dahod Road Mandideep, Raisen, Madhya Pradesh, India – 462046.
As per the financials filed for FY 2024, the company reported a revenue of ₹32.2 Lakh, a growth of 122% compared to the previous year. For the same year it recorded a net profit of ₹1.91 Lakh (net margin 5.9%) and EBITDA of ₹2.68 Lakh (EBITDA margin 8.3%).
Scynor Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-35-0002557).
Company details
Recognitions & Rankings of Scynor Pharmaceuticals
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MP-35-0002557
Contact details
Scynor Pharmaceuticals Private Limited's registered office is in Raisen, Madhya Pradesh.
- Registered Address215 Sheetal Mega City Phase 2 Dahod Road Mandideep, Raisen, Madhya Pradesh, India – 462046
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Scynor Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Scynor Pharmaceuticals Private Limited, buy the company report.
Financials of Scynor Pharmaceuticals Private Limited
FY 2025 filings availableScynor Pharmaceuticals Private Limited reported revenue of ₹32.2 Lakh (up 122% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 122% in the latest year. EBITDA rose 268% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.68 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.91 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 8.3% | |||
| Net Profit Margin | 5.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Scynor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Scynor Pharmaceuticals Private Limited
Scynor Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Kumar Tiwari | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Phul Kumari Tiwari | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Savita Tiwari | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Scynor Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nano Pharmaceuticals Private Limited | ₹32.34 Lakh (FY 2024) | 6.0% | Indore, Madhya Pradesh, India | |||
| Shinevet Pharmaceuticals Private Limited | ₹32.29 Lakh (FY 2025) | 51.0% | Gorakhpur, Uttar Pradesh, India | |||
| Scynor Pharmaceuticals Private Limitedthis company | ₹32.2 Lakh (FY 2024) | ₹1.91 Lakh | 5.9% | 122.0% | Raisen, Madhya Pradesh, India | |
| Forton Pharmaceuticals Private Limited | ₹32.12 Lakh (FY 2019) | 4.0% | Pune, Maharashtra, India | |||
| Soleil Pharmaceuticals Private Limited | ₹32.1 Lakh (FY 2025) | -22.0% | Chennai, Tamil Nadu, India | |||
| Moonlight Pharmaceuticals Private Limited | ₹32.07 Lakh (FY 2017) | 16.0% | Sri Ganganagar, Rajasthan, India |
To see the full peer comparison of Scynor Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Scynor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Scynor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Scynor Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Scynor Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Deepak Kumar Tiwari was appointed as Director on 12 Feb 2021.
Frequently asked questions
Scynor Pharmaceuticals is an active private limited company based in Raisen, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 12 February 2021 (5+ years old) and is registered under CIN U24239MP2021PTC054905.
Scynor Pharmaceuticals has 3 current directors:
- Deepak Kumar Tiwari - Director
- Phul Kumari Tiwari - Director
- Savita Tiwari - Director
The latest financial statements of Scynor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Scynor Pharmaceuticals is U24239MP2021PTC054905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scynor Pharmaceuticals was incorporated on 12 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Scynor Pharmaceuticals by revenue are Nano Pharmaceuticals Private Limited, Shinevet Pharmaceuticals Private Limited, Forton Pharmaceuticals Private Limited, Soleil Pharmaceuticals Private Limited, Moonlight Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Deepak Kumar Tiwari was appointed as Director on 12 Feb 2021. Phul Kumari Tiwari was appointed as Director on 12 Feb 2021. Savita Tiwari was appointed as Director on 12 Feb 2021.
Yes, Scynor Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Scynor Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-35-0002557).
The registered office of Scynor Pharmaceuticals is at 215 Sheetal Mega City Phase 2 Dahod Road Mandideep, Raisen, Madhya Pradesh, India – 462046.
Scynor Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

